Day: June 6, 2023

Moving around metropolitan areas can present challenges for individuals who are obese or have height limitations, as many public spaces are not designed to accommodate their needs. However, a new law adds weight and height to the list of characteristics that are protected from discrimination in New York City. Aron Ranen has the story.
…

China, where COVID-19 was first identified in humans more than three years ago, expects its current wave of infection to hit as many as 65 million cases per week by late June, according to official accounts of models presented at a medical conference.

While that may be an exhausting number to a post-pandemic world wearied by a still rising toll of 767 million confirmed cases and more than 6.9 million deaths, the predicted onslaught in China comes with less severe symptoms, Wang Guiqiang, director of the Department of Infectious Diseases at Peking University First Hospital, told the official newspaper Beijing Daily.

And, experts say, the outbreak is likely to be confined to China. Raj Rajnarayanan, assistant dean of research and associate professor at the New York Institute of Technology and a top COVID-variant tracker, told Fortune that when it comes to XBB variants, “the rest of the world has seen them all.” But up until recently, “China hasn’t.”

Respiratory disease specialist Zhong Nanshan, who spoke on May 22 at a conference in the southern city of Guangzhou, said the current wave of infections that started in late April was “anticipated.” His modeling suggested that by the end of June, the weekly number of infections will peak at 65 million, according to the official Global Times.

After Beijing relaxed the draconian lockdowns enforced under its “zero-COVID” policy, an omicron variant different from the current one ripped through China in December 2022 and January 2023.

About 80% of China’s 1.4 billion people were infected during that wave, Wu Zunyou, chief epidemiologist at the Chinese Center for Disease Control and Prevention, said in January, CNN reported. Patients packed hospitals and families waited for days to cremate those who died.

The latest COVID wave is something most people do not take seriously, said Mr. Lin, who requested anonymity due to the sensitivity of the issue. The resident of Quanzhou in Fujian province said, “They go about their activities normally and don’t do any protection. No one wears masks.”

Mr. Lin told VOA Mandarin he was infected in mid-December 2022, soon after Beijing lifted the lockdowns that had sent the world’s second-largest economy into a tailspin.

He realized he was infected — again — in May. Mr. Lin said he knew others who were likely reinfected and didn’t even bother to take a COVID test because their symptoms were so mild.

Mr. Zhang, who was infected for the first time in December, told VOA Mandarin he was infected a second time on a business trip to Shanghai and Beijing in May. The Hunan province resident, who asked to use a pseudonym to avoid attracting official attention, thought he had caught a cold because of the air conditioning he encountered on his trip.

But he took a test while still in Beijing and with a positive result, ended up at a hospital where he said a doctor told him, “People all over the country are like this. No need for medical attention at all. Just go home.”

After suffering four days with insomnia, loss of appetite and recurring fever, Mr. Zhang went to another Beijing hospital. Admitted, he was given Paxlovid, an anti-coronavirus drug developed by Pfizer.

“I took the medicine at noon and felt relieved at night,” he told VOA Mandarin.

During his hospital stay, Mr. Zhang said, “All the infectious disease wards were full, and there was a long queue to get an appointment. The hospital used wards of other departments for patients from the Infectious Diseases Department.”

Jin Dong-yan, a biochemistry professor with the Li Ka-shing Faculty of Medicine at the University of Hong Kong, told VOA Mandarin there is not much difference between the current situation in China and in the U.S., but the Chinese media devote more coverage to the outbreak.

Jin said, “In fact, looking at the data, the U.S. has experienced about four peaks after the outbreak last year, but each peak is getting smaller and smaller.”

The United States, by comparison, was reporting more than 5 million cases a week at its most recent peak in January.

The World Health Organization declared COVID-19 over as a global health emergency on May 5.

Like the U.S., China stopped providing weekly case updates in May, making it difficult to know the true extent of the current outbreak.

The U.S. Centers for Disease Control and Prevention recorded more than 1.1 million deaths in the U.S. involving COVID-19 from January 4, 2020, to May 27, 2023. 

In China, from January 3, 2020, to May 31, 2023, there have been almost 100 million confirmed cases of COVID-19, with more than 120,000 deaths reported by Beijing to WHO.

Adrianna Zhang contributed to this report.
…

There are renewed concerns North Korea’s army of hackers is targeting financial institutions to prop up the regime in Pyongyang and possibly fund its weapons programs.

A report published Tuesday by the cybersecurity firm Recorded Future finds North Korean aligned actors have been spoofing well-known financial firms in Japan, Vietnam and the United States, sending out emails and documents that, if opened, could grant the hackers access to critical systems.

“The targeting of investment banking and venture capital firms may expose sensitive or confidential information of these entities or their customers,” according to the report by Recorded Future’s Insikt Group.

“[It] may result in legal or regulatory action, jeopardize pending business negotiations or agreements, or expose information damaging to the company’s strategic investment portfolio,” it said.

The report said the most recent cluster of activity took place between September 2022 and March 2023, making use of three new internet addresses and two old addresses, and more than 20 domain names.

Some of the domains imitated those used by the targeted financial institutions.

Recorded Future’s named the group behind the attacks Threat Activity Group 71 (TAG-71), which is also known as APT38, Bluenoroff, Stardust Chollima and the Lazarus Group.

This past April, the U.S. sanctioned three individuals associated with the Lazarus Group, accusing them of helping North Korea launder stolen virtual currencies and turn it into cash.

U.S. Treasury officials levied additional sanctions just last month against North Korea’s Technical Reconnaissance Bureau, which develops tools and operations to be carried out by the Lazarus Group.

The Lazarus Group is believed to be responsible for the largest theft of virtual currency to date, stealing approximately $620 million connected to a popular online game in Match 2022.

Earlier this month, U.S. and South Korean agencies issued a warning about another set of North Korean cyber actors impersonating think tanks, academic institutions and journalists in an ongoing attempt to collect intelligence.

 
…

Japan announced Tuesday that it joined the United States and Australia in signing a $95 million undersea cable project that will connect East Micronesia island nations to improve networks in the Indo-Pacific region where China is increasingly expanding its influence.

The approximately 2,250-kilometer (1,400-mile) undersea cable will connect the state of Kosrae in the Federated State of Micronesia, Tarawa in Kiribati and Nauru to the existing cable landing point located in Pohnpei in Micronesia, according to the Japanese Foreign Ministry.

Japan, the United States and Australia have stepped up cooperation with the Pacific Islands, apparently to counter efforts by Beijing to expand its security and economic influence in the region.

In a joint statement, the parties said next steps involve a final survey and design and manufacturing of the cable, whose width is about that of a garden hose. The completion is expected around 2025.

The announcement comes just over two weeks after leaders of the Quad, a security alliance of Japan, the United States, Australia and India, emphasized the importance of undersea cables as a critical component of communications infrastructure and the foundation for internet connectivity.

“Secure and resilient digital connectivity has never been more important,” Matthew Murray, a senior official in the U.S. State Department’s Bureau of East Asian and Pacific Affairs, said in a statement. “The United States is delighted to be part of this project bringing our region closer together.”

NEC Corp., which won the contract after a competitive tender, said the cable will ensure high-speed, high-quality and more secure communications for residents, businesses and governments in the region, while contributing to improved digital connectivity and economic development.

The cable will connect more than 100,000 people across the three Pacific countries, according to Kazuya Endo, director general of the international cooperation bureau at the Japanese Foreign Ministry.

 
…

New advances in the fight against a range of cancers have been revealed at the annual meeting of the American Society of Clinical Oncology (ASCO), which wraps up in Chicago on Tuesday.

Here are some of the announcements that have most excited experts.

Lung cancer

One of the trial results that caused a stir in Chicago has raised hopes for a new weapon against lung cancer, the deadliest of all cancers.

The treatment osimertinib was shown to halve the risk of death from a certain type of lung cancer when taken daily after surgery to remove the tumor.

Developed by the pharmaceutical group AstraZeneca, the daily pill targets patients with non-small cell cancer — by far the most common type — as well as a mutation of their epidermal growth factor receptor, or EGFR.

Iris Pauporte, head of research at France’s League Against Cancer, told AFP the advance was a “big ray of hope” for this type of cancer, for which progress has been slow.

Muriel Dahan, head of research at Unicancer, said that if the results are confirmed, it “should change” common practice in treating this kind of lung cancer.

Systematic testing for the EGFR mutation would also become necessary for lung cancer patients, she added.

Brain cancer

Another treatment, called vorasidenib, was found to significantly prolong the progression-free survival of patients with brain tumor glioma, according to clinical trial results.

The daily pill, developed by French pharma firm Servier, aims to block an enzyme responsible for the progression of some brain cancers, which have been particularly difficult to treat.

Patrick Therasse, Servier’s vice-president of oncology research, told AFP that there “have been few therapeutic advances for brain tumors over the last 20 years.”

“Thanks to our targeted treatment, patients avoided cancer progression for 27.7 months, compared to 11.1 months” for those taking a placebo, he added.

Fabrice Andre, head of research at France’s Gustave Roussy cancer center, said “precision medicine opens a door for a disease for which there was nothing until now.”

“It means that science can unblock situations that were catastrophic,” he told AFP.

Unicancer’s Dahan said it was important to “remain cautious” but added that “this could become the new therapeutic standard — depending on further trials.”

Breast cancer

Preliminary trial results also released in Chicago indicated the drug ribociclib reduced the risk of breast cancer recurring by 25 percent for a large group of early-stage survivors.

The drug, developed by Swiss pharmaceutical maker Novartis, is already widely approved around the world. It was tested in combination with hormonal therapy.

ASCO expert Rita Nanda said it was a “very important and practice-changing clinical trial.”

Cervical cancer

There was also good news for patients with early-stage cervical cancer with a low risk of progression.

There was no greater risk of the cancer returning for patients who get a simple hysterectomy, in which the uterus and cervix are removed, than a radical hysterectomy, in which the uppermost part of the vagina is also removed, according to phase three trials.

League Against Cancer’s Pauporte said this was “good news,” adding that “it shows that it’s not just progress involving drugs that was important.”

Ovarian cancer

A trial also presented at ASCO showed that taking the antibody treatment mirvetuximab soravtansine significantly improved the survival rate of patients with ovarian cancer, a particularly deadly form of cancer.

ASCO expert Merry Jennifer Markham said the treatment “demonstrates progress and offers hope for these patients.”

Rectal cancer

Study results released in Chicago indicated that patients with locally advanced rectal cancer could receive chemotherapy without getting radiation therapy before undergoing surgery.

This would spare patients from the brutal side effects of radiation.

Vaccines

Vaccines that treat existing cancer have long been a goal of the medical community.

Preliminary studies announced at the ASCO meeting involved vaccines targeting lung cancer, head and neck cancers, brain tumor glioblastoma and the cancer-causing HPV virus.

Christophe Le Tourneau, an oncologist at France’s Curie Institute which presented a study about a vaccine for a certain form of HPV, said there has been “significant technological progress” in the area recently.

“Therapeutic vaccines, we talk about them more and more, and there are more and more trials in progress,” he said.
…

The U.S. Department of Homeland Security is looking at how artificial intelligence can be used to help identify goods made with child or forced labor and prevent those goods from entering the country. VOA’s Julie Taboh has more. VOA footage by Adam Greenbaum.
…

Top Chinese officials told Elon Musk about plans to launch new regulations on artificial intelligence on his recent trip to the Asian giant, the tech billionaire said Monday, in his first comments on the two-day visit.

The Twitter owner and Tesla CEO — one of the world’s richest men — held meetings with senior officials in Beijing and employees in Shanghai last week.

“Something that is worth noting is that on my recent trip to China, with the senior leadership there, we had, I think, some very productive discussions on artificial intelligence risks, and the need for some oversight or regulation,” Musk said. “And my understanding from those conversations is that China will be initiating AI regulation in China.”

Praised China

Musk, whose extensive interests in China have long raised eyebrows in Washington, spoke about the exchange in a livestreamed Twitter discussion with Democratic presidential hopeful and vaccine conspiracy theorist Robert Kennedy Jr., the nephew of the late U.S. President John F. Kennedy.

Musk did not tweet while in China and Tesla has not released readouts of Musk’s meeting with officials.

But official Chinese channels said he lavished praise on the country, including for its “vitality and promise,” and expressed “full confidence in the China market.”

Several Chinese companies have been rushing to develop AI services that can mimic human speech since San Francisco-based OpenAI launched ChatGPT in November.

But rapid advancements have stoked global alarm over the technology’s potential for disinformation and misuse.

Musk didn’t elaborate on his discussions in China but was likely referring to a sweeping draft law requiring new AI products to undergo a security assessment before release and a process ensuring that they reflect “core socialist values.”

The “Administrative Measures for Generative Artificial Intelligence Services” edict bans content promoting “terrorist or extremist propaganda,” “ethnic hatred” or “other content that may disrupt economic and social order.”

Under Beijing’s highly centralized political system, the measures are almost certain to become law.

Describes meetings as ‘promising’

Musk has caused controversy by suggesting the self-ruled island of Taiwan should become part of China — a stance that was welcomed by Chinese officials but which deeply angered Taipei.

The 51-year-old South African native described his meetings in China as “very promising.”

“I pointed out that if there is a digital super intelligence that is overwhelmingly powerful, developed in China, it is actually a risk to the sovereignty of the Chinese government,” he said. “And I think they took that concern to heart.”
…